Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

Was I properly warned about the side effects of Depakote/Depakene/Depacon?

September 27, 2017 By Law Offices of Thomas J. Lamb, P.A.


As discussed in my last article, “Should I have been prescribed Depakote / Depakene / Depacon?“, it is extremely important that these drugs are properly prescribed, given their devastating potential fetal side effects.

Additionally, any time that Depakote / Depakene / Depacon was prescribed to a female patient, doctors should have warned the woman about the possible fetal side effects of “major congenital malformations, particularly neural tube defects (e.g., spina bifida)” and / or “decreased IQ scores.”

However, according to a recent Reuters article, many pregnant women taking these drugs do not feel as though they were adequately warned of the potentially life-altering side effects.

While the drug manufacturer, Sanofi, claims that the labels provide sufficient warnings, many women disagree.

The aforementioned article discusses a recent public hearing held by the European Medicines Agency (EMA) on patients’ experiences with drugs containing valproic acid–the main active ingredient in Depakote, Depakene, and Depacon.  The article provides the following information:

[R]ecent surveys in the United Kingdom showed almost 70 percent of women taking the drug had not received adequate advice.

Clare Pelham, speaking on behalf of Britain’s Epilepsy Society, said warnings on medicine packages and leaflets were insufficient and that patients needed “tailored conversations” with healthcare professionals.

In the United States, as revisions of FDA drug labels are released and new or increased warnings are added to those labels, doctors should keep current with the prescribing information for the medications they use to treat their patients.

Often when a new FDA drug label is released with increased warnings of particularly severe or life-threatening possible side effects, a “Dear Doctor” letter is also issued to providers, so that they may adequately warn patients.

The information provided by the FDA should lead to more adequate warnings of the potential devastating side effects of these drugs.

Such warnings are warranted if:

  1. the female patient who was prescribed Depakote / Depakene / Depacon was of childbearing potential; and,
  2. Depakote / Depakene / Depacon was deemed “essential to the management of her medical condition,”

Her doctor should then have warned her that:

  1. the drugs could cause “major congenital malformations, particularly neural tube defects (e.g., spina bifida)” and / or “decreased IQ scores”; and,
  2. “effective contraception” was necessary so as to prevent pregnancy and any fetal exposure to these drugs.

Any warning that fails to address these key points could be deemed inadequate, and potentially serve as the basis of a medical malpractice case if an unborn child was exposed to the drugs, then was born with one of the aforementioned side effects.

For more information on Depakote / Depakene / Depacon and the issue of adequate warnings, visit our website.

 

Written by: Heather Helmendach, Legal Assistant
Law Offices of Thomas J. Lamb, P.A.


Drug Injury Watch
: Side Effects News & Reports

Drug Injury Law: Medical & Legal Information

Filed Under: Unsafe Drugs Tagged With: bipolar disorder drugs side effects, birth defects, depacon, depakene, depakote, EMA, epilepsy drugs side effects, European Medicines Agency, fetal birth defects causes, medical malpractice cases, prescription drug side effects, spina bifida causes, Stavzor, valproate, valproic acid

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.